Snehlata Tripathi
About Snehlata Tripathi
Snehlata Tripathi is the Director of Process Development at Wave Life Sciences, where she has worked since 2016. She holds a Ph.D. from the University of Allahabad and has extensive experience in drug development, particularly in targeted lipid-based and polymer-based nanoparticles for oncology applications.
Current Role at Wave Life Sciences
Snehlata Tripathi serves as the Director of Process Development at Wave Life Sciences, a position she has held since 2016. In this role, she oversees the development of processes essential for the manufacturing of drug substances and active pharmaceutical ingredients. Her work focuses on ensuring compliance with Good Laboratory Practice (GLP) and current Good Manufacturing Practice (cGMP) standards. She is involved in the development of targeted lipid-based nanoparticles and polymer-based nanoparticles for oncology applications, contributing to the advancement of innovative therapies.
Previous Experience at Preceres LLC
Before joining Wave Life Sciences, Snehlata Tripathi worked at Preceres LLC as a Principal Scientist from 2014 to 2016 in Cambridge, MA. During her tenure, she focused on various aspects of drug development, leveraging her expertise in Chemistry, Manufacturing, and Controls (CMC) requirements. Her role involved the development and optimization of processes critical to the pharmaceutical industry.
Experience at Enzon Pharmaceuticals
Snehlata Tripathi was employed at Enzon Pharmaceuticals as Scientist II from 2008 to 2011 in Piscataway, NJ. In this capacity, she contributed to research and development efforts, applying her knowledge in chemistry to support the development of pharmaceutical products. Her work during this period helped enhance her skills in process development and drug formulation.
Educational Background
Snehlata Tripathi earned her Doctor of Philosophy (Ph.D.) from the University of Allahabad, where she also completed her Master’s Degree in Organic Chemistry. Additionally, she studied at the University of Medicine and Dentistry of New Jersey, focusing on the synthesis of PNA-peptide conjugates and conducting antiviral and virucidal studies. This extensive educational background has equipped her with a strong foundation in chemistry and drug development.
Technical Contributions and Expertise
Throughout her career, Snehlata Tripathi has authored critical technical documents, including batch records and standard operating procedures (SOPs) for technology transfer to Contract Manufacturing Organizations (CMOs). Her expertise in the development of targeted lipid-based nanoparticles and polymer-based nanoparticles for oncology applications has contributed to the intellectual property development in the field of process development at Wave Life Sciences.